← Back to the biomarker database

Pantoprazol: the pathway in the body

Pantoprazol is part of the pathway “Pantoprazol”. This page shows the whole pathway; the station of Pantoprazol is highlighted.

Where this laboratory value sits: Pantoprazole — enteric-coated tablet. Pantoprazole is swallowed as an enteric-coated tablet. The coating holds the substance together in the acidic stomach; the label calls this a delayed-release form. It thus reaches the small bowel unchanged. Source 1, 9

In brief

Pantoprazole is a proton pump inhibitor. In the parietal cell of the stomach it is converted into its active form and blocks the H⁺/K⁺-ATPase — the enzyme that moves hydrogen ions into the stomach. The bond is lasting: the cell must build new pumps. The pH rises.

What this is about

Gastric acid is the condition for three steps that involve nutrients:

Pantoprazole blocks the proton pump of the parietal cell. As the pH in the stomach rises, these three steps lose their condition — each runs more slowly, each at its own place. The pump is blocked; the steps behind it are slowed, not switched off.

What this means in an individual case depends on many things and belongs in a conversation with a doctor or health practitioner.

Source 4, 5, 6, 7, 8, 9

17 stations · 10 sources
ORYPath of the substanceAction in the stomachH⁺/K⁺-ATPaseK⁺ in exchangeMg-ATPweak baseacidic pHPepsinDcytbAscorbateDMT1H⁺acidic pHconversion in acidblocksactivates pepsinogenkeeps iron dissolveddissolves calcium saltsPantoprazoleenteric-coated tabletRelease past the stomachcoating dissolves therePassage into the bloodacross the gut wallParietal cell of stomachcell of the gastric liningAcidic canaliculuschannel of the parietal cellSulfenamideactive form, only in acidH⁺ in the parietal cellstarting point of the acidH⁺ in the gastric lumenreleased stomach acidpH in the gastric lumenset by the pumpPepsinogenprecursor from chief cellsPepsinprotein-splitting enzymeFree vitamin B12out of the food proteinIron(III) from foodferric ironIron(II)ferrous ironIron in the gut cellpassage via DMT1Calcium saltsfrom foodDissolved calciumuptake in small bowel

Swipe the graphic sideways

The pathway step by step

Each station states what the compound does there. Three signs: ↑ supplies — builds up or makes available · ↓ depletes — inhibits, consumes or withholds · ↕ both, depending on amount. Behind it stands what the statement rests on: established physiology, observed in studies, or contested. The signs do not grade; they name the direction.

  1. Pantoprazole → Release past the stomach Beyond the stomach the pH is higher. There the coating dissolves and frees the substance, so absorption begins only after the stomach. It thus escapes early conversion in the stomach. Source 1, 9↑ supplies Only in the less acidic small bowel is the substance released. It thus reaches the gut wall unchanged instead of turning into the active form too early in the stomach. established physiology Source 1, 9
    ⚖ When the balance tips

    too much — If a lot of the substance is released, the level in the blood rises quickly and then falls again within a few hours, because the liver breaks it down swiftly.

    too little — If the coating dissolves late or little is released, the blood level rises later and less steeply.

    established physiology · Source 9

  2. Release past the stomach → Passage into the blood The substance passes through the wall of the small bowel into the blood and travels around the body with the blood. The liver breaks it down quickly, mainly via CYP2C19. Source 1↑ supplies In the blood pantoprazole is largely bound to proteins and present only briefly; the liver breaks it down mainly via CYP2C19. The action lasts longer because the bond to the pump is lasting. established physiology Source 9, 1
    ⚖ When the balance tips

    too much — If a lot of the substance is present in the blood, for example when CYP2C19 works slowly, it stays available longer and reaches more pumps in the parietal cells.

    too little — If little of the substance is present in the blood, for example because CYP2C19 breaks it down quickly, less reaches the parietal cells, and more pumps stay free.

    established physiology · Source 9, 1

  3. Passage into the blood → Parietal cell of stomach From the blood the substance reaches the parietal cells of the gastric lining. These cells release the stomach acid. Here it meets acid and pump at once. Source 1↑ supplies Only in the parietal cell does pantoprazole find both at once: the acid for its conversion and the pump as its target. This is why it acts there selectively and hardly at other cells. established physiology Source 1
    ⚖ When the balance tips

    too much — If the parietal cell is highly active, many pumps are built into the membrane of the canaliculus, and more of them can be bound.

    too little — If the parietal cell is at rest, most pumps lie in inner vesicles, there is little acid, and little of the substance is converted; resting pumps stay untouched.

    established physiology · Source 1, 2

  4. Parietal cell of stomach → Acidic canaliculus · weak base Pantoprazole is a weak base and collects in the canaliculus, the acidic channel of the parietal cell into which the acid is released. It thus accumulates where the pump works. Source 1, 3↑ supplies As a weak base, pantoprazole picks up a proton in the acid and can then hardly leave through the membrane. It thus accumulates exactly where the pump works. established physiology Source 1, 3
    ⚖ When the balance tips

    too much — If a lot of the substance collects in the canaliculus, much sulfenamide forms there, and a larger share of the active pumps is bound.

    too little — If little collects because the canaliculus is hardly acidic, little is converted; the substance leaves again and is broken down.

    established physiology · Source 1, 3

  5. H⁺ in the parietal cell → H⁺ in the gastric lumen H⁺/K⁺-ATPase · K⁺ in exchange, Mg-ATP The H⁺/K⁺-ATPase exchanges one H⁺ from the cell for one K⁺ from outside. It splits ATP for this and works as a P-type ATPase with magnesium. When it is bound, less acid reaches the stomach. Source 2↑ supplies The released H⁺ form the hydrochloric acid of the stomach. It is the condition for pepsin to form, for iron(III) to stay dissolved and for calcium salts to dissolve. established physiology Source 2, 4, 6, 8
    ⚖ When the balance tips

    too much — If many pumps work, a lot of acid collects in the stomach, and the pH falls low.

    too little — If few pumps work, little acid reaches the stomach; newly built pumps restore the release step by step.

    established physiology · Source 1, 2

  6. H⁺ in the gastric lumen → pH in the gastric lumen The released H⁺ ions make the stomach contents acidic. If part of the pumps is blocked, fewer H⁺ reach the lumen and the pH rises. The steps behind it then run more slowly. Source 1, 2↑ supplies The pH is the control variable: the more acidic, the faster pepsin forms and the more iron(III) and calcium stay dissolved. As it rises, these steps run more slowly; they are not switched off. established physiology Source 4, 6, 8
    ⚖ When the balance tips

    too much — If the stomach contents are very acidic, pepsin forms quickly, and iron and calcium salts dissolve largely.

    too little — If little stomach acid is present and the pH is high, more pepsinogen stays inactive, and more iron(III) and calcium carbonate stay undissolved.

    established physiology · Source 4, 6, 8

  7. Pepsinogen → Pepsin · acidic pH At acidic pH pepsinogen unfolds itself and becomes pepsin. This step depends on the pH: as it rises, less pepsin forms — and without pepsin vitamin B12 stays bound to the food protein. It works only in acid. Source 4↑ supplies Pepsin splits food protein into shorter pieces and in doing so frees bound vitamin B12. It works only in acid; as the pH rises, it becomes inactive. established physiology Source 4, 5
    ⚖ When the balance tips

    too much — If a lot of pepsin is active, protein is broken up quickly, and the freed vitamin B12 binds to haptocorrin in the stomach.

    too little — If little pepsin is active because little stomach acid is present, more vitamin B12 stays bound in food protein and does not reach its transport proteins.

    established physiology · Source 4, 5

  8. Pepsin → Free vitamin B12 Pepsin Acid and pepsin release vitamin B12 from the protein of the food. Only then can it bind to the transport proteins of the body. After that it needs intrinsic factor. Source 5↑ supplies Free vitamin B12 binds first to haptocorrin, then in the small bowel to intrinsic factor. Only in this complex does the ileum absorb it via the cubam receptor. established physiology Source 5
    ⚖ When the balance tips

    too much — If a lot of vitamin B12 is freed, it is absorbed via intrinsic factor until its binding sites are occupied; most of the rest stays in the gut.

    too little — If little vitamin B12 is freed, little of it reaches intrinsic factor, and less passes into the blood via the ileum; the liver holds a store that lasts a long time.

    established physiology · Source 5

  9. Iron(III) from food → Iron(II) Dcytb · Ascorbate The ferrireductase Dcytb at the gut cell converts ferric iron into ferrous iron. Ascorbate supplies the electrons for this. Only this form can be carried by DMT1. Source 7↑ supplies Dcytb turns iron(III) into the form that DMT1 can carry; ascorbate supplies the electrons. Without this step, ferric iron stays outside. established physiology Source 7
    ⚖ When the balance tips

    too much — If a lot of iron(II) forms, DMT1 absorbs more, until the gut cell reduces the formation of DMT1 and Dcytb via its regulators.

    too little — If little iron(II) forms, for example because little ascorbate or little dissolved iron(III) is present, DMT1 receives little that it can carry.

    established physiology · Source 7, 6

  10. Iron(II) → Iron in the gut cell DMT1 · H⁺ The transporter DMT1 moves only ferrous iron and carries it together with one H⁺ into the gut cell. The gut cell adjusts the number of carriers. Source 6↑ supplies DMT1 uses the H⁺ gradient at the gut cell as its drive and carries iron(II) together with one H⁺. Here too an acidic milieu at the surface sustains the step. established physiology Source 6
    ⚖ When the balance tips

    too much — If a lot of iron enters the gut cell, it makes less DMT1 and Dcytb and absorbs less afterwards.

    too little — If little iron enters the gut cell, it makes more DMT1 and Dcytb and draws on the available iron more thoroughly.

    established physiology · Source 7, 6

  11. Calcium salts → Dissolved calcium · acidic pH Acidic gastric juice dissolves the salt. Only dissolved calcium is taken up in the small intestine. As pH rises, less dissolves — more so for carbonate than for citrate. It then passes the gut wall. Source 8↑ supplies Dissolved calcium is the form that passes the gut wall. How much of it arises from calcium carbonate depends partly on the acidity of the stomach. established physiology Source 8
    ⚖ When the balance tips

    too much — If a lot of dissolved calcium is present, more of it passes in the small bowel, until the transport routes of the gut wall are saturated.

    too little — If little dissolved calcium is present, less passes over. How strongly a high gastric pH slows the dissolving of carbonate depends, in studies, on the other stomach contents.

    observed in studies · Source 8

Further stations

What needs an acidic environment

What takes part in these steps

What the prescribing information states

Nine trials in the United States with 1,473 adults on pantoprazole, 345 on a comparator and 82 on placebo. Listed are the reactions that occurred in more than 2 of 100 participants. The figures apply to these trials.

How to read the table: what matters is not the single figure but the comparison within the row. Nausea occurred more often on placebo than on pantoprazole; headache about as often as on the comparators.

Pantoprazole (1,473)Comparator (345)Placebo (82)
Headache12.2%12.8%8.5%
Diarrhoea8.8%9.6%4.9%
Nausea7.0%5.2%9.8%
Abdominal pain6.2%4.1%6.1%
Vomiting4.3%3.5%2.4%
Flatulence3.9%2.9%3.7%
Dizziness3.0%2.9%1.2%
Arthralgia2.8%1.4%1.2%

Further reactions have been reported after approval. The prescribing information states explicitly that neither a frequency nor a causal relationship can be derived from them; they are therefore not listed here.

Sources

  1. Shin JM, Sachs G. Pharmacology of proton pump inhibitors. Curr Gastroenterol Rep 2008 · PubMed 19006606
  2. Shin JM, Munson K et al. The gastric HK-ATPase: structure, function, and inhibition. Pflugers Arch 2009 · PubMed 18536934
  3. Shin JM, Cho YM, Sachs G. Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors. J Am Chem Soc 2004 · PubMed 15212527
  4. Kageyama T. Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development. Cell Mol Life Sci 2002 · PubMed 11915945
  5. Nielsen MJ, Rasmussen MR et al. Vitamin B12 transport from food to the body's cells — a sophisticated, multistep pathway. Nat Rev Gastroenterol Hepatol 2012 · PubMed 22547309
  6. Mackenzie B, Garrick MD. Iron Imports. II. Iron uptake at the apical membrane in the intestine. Am J Physiol Gastrointest Liver Physiol 2005 · PubMed 16286504
  7. Lane DJ, Bae DH et al. Duodenal cytochrome b (DCYTB) in iron metabolism: an update on function and regulation. Nutrients 2015 · PubMed 25835049
  8. Wood RJ, Serfaty-Lacrosniere C. Gastric acidity, atrophic gastritis, and calcium absorption. Nutr Rev 1992 · PubMed 1570081
  9. US prescribing information (United States): Pantoprazole Sodium Delayed-Release Tablets, DailyMed, version of 28 Aug 2026, sections 12.1 Mechanism of Action and 12.3 Pharmacokinetics · Prescribing information
  10. US prescribing information (United States): Pantoprazole Sodium Delayed-Release Tablets, DailyMed, version of 14 Sept 2026, sections 6.1 Clinical Trials Experience and 6.2 Postmarketing Experience · Prescribing information

Whole pathway: Pantoprazol

As of 2026-09-23. Draft, written by Claude to schema v2; sources checked in PubMed; expert approval pending
Legal notice Privacy policy All biomarkers